Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pesavento

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Cureus|July 23, 2019
Successful Treatment and Five Years of Disease-free Survival in a Donor Transmitted Metastatic Melanoma with Ipilimumab TherapyPriyamvada Singh, Deepali Pandey, Brad Rovin, et al.
Clinical Transplantation|May 25, 2016
High mortality in diabetic recipients of high KDPI deceased donor kidneysRonald P Pelletier, Todd E Pesavento, Amer Rajab, et al.
Diabetes, Obesity & Metabolism|December 20, 2018
Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipientsPriyamvada Singh, Todd E Pesavento, Kenneth Washburn, et al.
Journal of the American Society of Nephrology : JASN|June 1, 1996
Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: results of a prospective studyT E Pesavento, P A Jones, B A Julian, et al.
Postgraduate Medical Journal|April 17, 2023
Rare oral lesions from cytomegalovirus in kidney transplantMohankumar Doraiswamy, Todd E Pesavento, Deepali Pandey, et al.
Diabetes, Obesity & Metabolism|January 17, 2020
Comparison of the glucagon-like-peptide-1 receptor agonists dulaglutide and liraglutide for the management of diabetes in solid organ transplant: A retrospective studyPriyamvada Singh, Maryam Taufeeq, Todd E Pesavento, et al.
Kidney International Reports|April 14, 2025
Hemophagocytic Lymphohistiocytosis in Solid Organ TransplantsPriyamvada Singh, Mohankumar Doraiswamy, Alka Tyagi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2004
Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapyTodd E Pesavento, William H Bay, Garima Agarwal, et al.
Transplantation|March 19, 2014
Effects of cardiovascular comorbidity adjustment on SRTR risk-adjusted cox proportional hazard models of graft survivalRonald P Pelletier, Gary S Phillips, Amer Rajab, et al.
Kidney International|February 13, 2001
Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent yearsF G Cosio, T E Pesavento, K Osei, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Cureus|July 23, 2019
Successful Treatment and Five Years of Disease-free Survival in a Donor Transmitted Metastatic Melanoma with Ipilimumab TherapyPriyamvada Singh, Deepali Pandey, Brad Rovin, et al.
Clinical Transplantation|May 25, 2016
High mortality in diabetic recipients of high KDPI deceased donor kidneysRonald P Pelletier, Todd E Pesavento, Amer Rajab, et al.
Diabetes, Obesity & Metabolism|December 20, 2018
Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipientsPriyamvada Singh, Todd E Pesavento, Kenneth Washburn, et al.
Journal of the American Society of Nephrology : JASN|June 1, 1996
Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: results of a prospective studyT E Pesavento, P A Jones, B A Julian, et al.
Postgraduate Medical Journal|April 17, 2023
Rare oral lesions from cytomegalovirus in kidney transplantMohankumar Doraiswamy, Todd E Pesavento, Deepali Pandey, et al.
Diabetes, Obesity & Metabolism|January 17, 2020
Comparison of the glucagon-like-peptide-1 receptor agonists dulaglutide and liraglutide for the management of diabetes in solid organ transplant: A retrospective studyPriyamvada Singh, Maryam Taufeeq, Todd E Pesavento, et al.
Kidney International Reports|April 14, 2025
Hemophagocytic Lymphohistiocytosis in Solid Organ TransplantsPriyamvada Singh, Mohankumar Doraiswamy, Alka Tyagi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2004
Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapyTodd E Pesavento, William H Bay, Garima Agarwal, et al.
Transplantation|March 19, 2014
Effects of cardiovascular comorbidity adjustment on SRTR risk-adjusted cox proportional hazard models of graft survivalRonald P Pelletier, Gary S Phillips, Amer Rajab, et al.
Kidney International|February 13, 2001
Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent yearsF G Cosio, T E Pesavento, K Osei, et al.
Pageof 5